US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist
  • 0.820
  • -0.025-2.96%
Close Oct 31 16:00 ET
  • 0.820
  • 0.0000.00%
Post 20:02 ET
45.51MMarket Cap-2827P/E (TTM)

Icecure Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
7.90%1.01M
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
Operating revenue
7.90%1.01M
4.65%743K
4.67%3.23M
33.65%1.26M
-48.42%327K
22.48%937K
-4.95%710K
-25.45%3.09M
-32.15%939K
-6.90%634K
Cost of revenue
-4.37%481K
21.54%474K
17.62%1.93M
43.51%686K
-25.21%350K
32.02%503K
24.60%390K
-15.59%1.64M
-35.49%478K
45.34%468K
Gross profit
22.12%530K
-15.94%269K
-10.03%1.3M
23.43%569K
-113.86%-23K
13.02%434K
-26.27%320K
-34.17%1.45M
-28.30%461K
-53.76%166K
Operating expense
-16.77%3.76M
-8.37%3.92M
-7.19%16.88M
-9.31%3.98M
-3.91%4.1M
-3.22%4.52M
-11.98%4.28M
52.56%18.18M
16.49%4.39M
32.97%4.27M
Selling and administrative expenses
-10.80%2.17M
-9.14%1.97M
-5.05%8.6M
-2.55%2.1M
-6.40%1.9M
1.08%2.44M
-12.13%2.17M
49.97%9.06M
-0.65%2.16M
22.07%2.03M
-Selling and marketing expense
6.79%1.26M
-3.44%1.04M
16.55%1.21M
-68.72%-2.02M
39.15%981K
49.87%1.18M
43.91%1.08M
56.01%1.04M
-117.60%-1.2M
19.09%705K
-General and administrative expense
-27.27%915K
-14.76%930K
-7.85%7.39M
22.92%4.12M
-30.64%919K
-22.54%1.26M
-36.50%1.09M
49.22%8.02M
23.30%3.36M
23.72%1.33M
Research and development costs
-23.76%1.59M
-7.58%1.95M
-9.32%8.27M
-15.82%1.88M
-1.65%2.2M
-7.80%2.08M
-11.82%2.11M
55.23%9.12M
39.73%2.24M
44.70%2.24M
Operating profit
20.90%-3.23M
7.76%-3.65M
6.95%-15.58M
13.15%-3.42M
-0.54%-4.12M
4.67%-4.08M
10.58%-3.96M
-72.14%-16.74M
-25.70%-3.93M
-43.89%-4.1M
Net non-operating interest income expense
-23.44%147K
-78.31%41K
486.61%924K
2,200.00%420K
186.05%123K
180.00%192K
959.09%189K
-39.77%-239K
37.50%-20K
213.16%43K
Total other finance cost
----
78.31%-41K
-486.61%-924K
-2,200.00%-420K
----
----
-959.09%-189K
39.77%239K
--20K
---43K
Other net income (expense)
Income before tax
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
Income tax
Net income
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
Net income continuous Operations
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
Minority interest income
Net income attributable to the parent company
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.78%-3.08M
4.22%-3.61M
13.70%-14.65M
24.22%-3M
1.43%-4M
13.98%-3.89M
15.27%-3.77M
-71.58%-16.98M
-25.06%-3.95M
-40.51%-4.06M
Basic earnings per share
33.33%-0.06
0.00%-0.08
30.43%-0.32
38.68%-0.065
22.73%-0.085
27.42%-0.09
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
Diluted earnings per share
33.33%-0.06
0.00%-0.08
30.43%-0.32
38.68%-0.065
22.73%-0.085
27.42%-0.09
33.33%-0.08
-31.43%-0.46
-4.95%-0.106
-18.28%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 7.90%1.01M4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K
Operating revenue 7.90%1.01M4.65%743K4.67%3.23M33.65%1.26M-48.42%327K22.48%937K-4.95%710K-25.45%3.09M-32.15%939K-6.90%634K
Cost of revenue -4.37%481K21.54%474K17.62%1.93M43.51%686K-25.21%350K32.02%503K24.60%390K-15.59%1.64M-35.49%478K45.34%468K
Gross profit 22.12%530K-15.94%269K-10.03%1.3M23.43%569K-113.86%-23K13.02%434K-26.27%320K-34.17%1.45M-28.30%461K-53.76%166K
Operating expense -16.77%3.76M-8.37%3.92M-7.19%16.88M-9.31%3.98M-3.91%4.1M-3.22%4.52M-11.98%4.28M52.56%18.18M16.49%4.39M32.97%4.27M
Selling and administrative expenses -10.80%2.17M-9.14%1.97M-5.05%8.6M-2.55%2.1M-6.40%1.9M1.08%2.44M-12.13%2.17M49.97%9.06M-0.65%2.16M22.07%2.03M
-Selling and marketing expense 6.79%1.26M-3.44%1.04M16.55%1.21M-68.72%-2.02M39.15%981K49.87%1.18M43.91%1.08M56.01%1.04M-117.60%-1.2M19.09%705K
-General and administrative expense -27.27%915K-14.76%930K-7.85%7.39M22.92%4.12M-30.64%919K-22.54%1.26M-36.50%1.09M49.22%8.02M23.30%3.36M23.72%1.33M
Research and development costs -23.76%1.59M-7.58%1.95M-9.32%8.27M-15.82%1.88M-1.65%2.2M-7.80%2.08M-11.82%2.11M55.23%9.12M39.73%2.24M44.70%2.24M
Operating profit 20.90%-3.23M7.76%-3.65M6.95%-15.58M13.15%-3.42M-0.54%-4.12M4.67%-4.08M10.58%-3.96M-72.14%-16.74M-25.70%-3.93M-43.89%-4.1M
Net non-operating interest income expense -23.44%147K-78.31%41K486.61%924K2,200.00%420K186.05%123K180.00%192K959.09%189K-39.77%-239K37.50%-20K213.16%43K
Total other finance cost ----78.31%-41K-486.61%-924K-2,200.00%-420K---------959.09%-189K39.77%239K--20K---43K
Other net income (expense)
Income before tax 20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M
Income tax
Net income 20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M
Net income continuous Operations 20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M
Minority interest income
Net income attributable to the parent company 20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.78%-3.08M4.22%-3.61M13.70%-14.65M24.22%-3M1.43%-4M13.98%-3.89M15.27%-3.77M-71.58%-16.98M-25.06%-3.95M-40.51%-4.06M
Basic earnings per share 33.33%-0.060.00%-0.0830.43%-0.3238.68%-0.06522.73%-0.08527.42%-0.0933.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11
Diluted earnings per share 33.33%-0.060.00%-0.0830.43%-0.3238.68%-0.06522.73%-0.08527.42%-0.0933.33%-0.08-31.43%-0.46-4.95%-0.106-18.28%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data